








key: cord-289744-suiqh3gv
authors: Lafolie, Jérémy; Labbé, André; L'Honneur, Anne Sophie; Madhi, Fouad; Pereira, Bruno; Decobert, Marion; Adam, Marie Noelle; Gouraud, François; Faibis, Frédéric; Arditty, Francois; Marque-Juillet, Stéphanie; Guitteny, Marie Aline; Lagathu, Gisele; Verdan, Matthieu; Rozenberg, Flore; Mirand, Audrey; Peigue-Lafeuille, Hélène; Henquell, Cécile; Bailly, Jean-Luc; Archimbaud, Christine
title: Assessment of blood enterovirus PCR testing in paediatric populations with fever without source, sepsis-like disease, or suspected meningitis: a prospective, multicentre, observational cohort study
date: 2018-10-30
journal: Lancet Infect Dis
DOI: 10.1016/s1473-3099(18)30479-1
sha: 
doc_id: 289744
cord_uid: suiqh3gv

BACKGROUND: Enteroviruses are the most frequent cause of acute meningitis and are seen increasingly in sepsis-like disease and fever without source in the paediatric population. Detection of enterovirus in cerebrospinal fluid (CSF) specimens by PCR is the gold standard diagnostic test. Our aim was to assess a method of detecting enterovirus in blood specimens by PCR. METHODS: We did a prospective, multicentre, observational study at 35 French paediatric and emergency departments in 16 hospitals. We recruited newborn babies (aged ≤28 days) and infants (aged >28 days to ≤2 years) with fever without source, sepsis-like disease, or suspected meningitis, and children (aged >2 years to ≤16 years) with suspected meningitis, who were admitted to a participating hospital. We used a standardised form to obtain demographic, clinical, and laboratory data, which were anonymised. Enterovirus PCR testing was done in blood and CSF specimens. FINDINGS: Between June 1, 2015, and Oct 31, 2015, and between June 1, 2016, and Oct 31, 2016, we enrolled 822 patients, of whom 672 had enterovirus PCR testing done in blood and CSF specimens. Enterovirus was detected in 317 (47%) patients in either blood or CSF, or both (71 newborn babies, 83 infants, and 163 children). Detection of enterovirus was more frequent in blood samples than in CSF specimens of newborn babies (70 [99%] of 71 vs 62 [87%] of 71; p=0·011) and infants (76 [92%] of 83 vs 62 [75%] of 83; p=0·008), and was less frequent in blood samples than in CSF specimens of children (90 [55%] of 163 vs 148 [91%] of 163; p<0·0001). Detection of enterovirus was more frequent in blood samples than in CSF specimens of infants aged 2 years or younger with fever without source (55 [100%] of 55 vs 41 [75%] of 55; p=0·0002) or with sepsis-like disease (16 [100%] of 16 vs nine [56%] of 16; p=0·008). Detection of enterovirus was less frequent in blood than in CSF of patients with suspected meningitis (165 [67%] of 246 vs 222 [90%] of 246; p<0·0001). INTERPRETATION: Testing for enterovirus in blood by PCR should be an integral part of clinical practice guidelines for infants aged 2 years or younger. This testing could decrease the length of hospital stay and reduce exposure to antibiotics for low-risk patients admitted to the emergency department with febrile illness. FUNDING: University Hospital Clermont-Ferrand.

Enteroviruses are the most frequent cause of paediatric aseptic meningitis and are attributed to more than 75% of viral meningitis cases in which a microorganism is identified. 1,2 Detection of enterovirus by RT-PCR from cerebrospinal fluid (CSF) specimens is recom mended for diagnosis of meningitis caused by entero virus. [3] [4] [5] Paediatricians are also confronted frequently with young infants with fever without source or sepsis-like diseases. These febrile illnesses account for 3·4-13·6% of cases seen in emergency departments. 6 Symptoms can result either from severe bacterial infection requiring admission to hospital and empirical antibiotic treatments or, most typically, from benign and spontaneously resolving viral infection; therefore, diagnosis is a challenge. Additional molecular tests are needed to speed up diagnosis of conditions asso ciated with enterovirus infections. 5 Several studies have evaluated testing blood specimens, [7] [8] [9] [10] [11] [12] but as yet no assessment has been done in a large cohort of paediatric patients.

The aim of our multicentre study was to assess detection of enterovirus by PCR in blood specimens of newborn babies, infants, and children with fever without source, sepsis-like disease, or suspected meningitis. 

We did a prospective, multicentre, observational study at 35 paediatric and emergency departments in 16 French hospitals. We restricted enrolment of patients to the seasonal period of increased enterovirus circulation in countries with a temperate climate. 13 We enrolled newborn babies (aged ≤28 days) and infants (aged >28 days to ≤2 years) with fever without source, sepsis-like disease, or suspected meningitis, and children (aged >2 years to ≤16 years) with suspected meningitis. All participants were admitted to one of the participating hospitals. We required an EDTA blood sample (plasma) obtained by venepuncture for participation. We also did lumbar puncture when clinically indicated.

We defined fever without source as a body temperature of 38°C or higher for less than 7 days in a child whose medical history and physical examination did not reveal the cause of the fever. 14 We defined sepsis as suspected or proven infection and at least two of another four criteria, one of which had to be abnormal temperature (>38·5°C or <36°C) or abnormal white-blood-cell count (elevated [>20 000 × 10⁹ per L] or depressed [<4000 × 10⁹ per L] for age), and the other criterion could be either tachycardia or bradycardia, or tachypnoea. Further criteria for sepsis were a platelet count lower than 100 000 × 10⁹ per L and C-reactive protein greater than 15 mg/L. 15 We defined meningitis as either the presence of age-specific pleocytosis or the presence of at least two of these neurological signs or symptoms: headache, nuchal rigidity, photophobia, bulging fontanelle, irritability, lethargy, nausea, vomiting, or positive Kernig's or Brudzinsky's signs. We defined pleocytosis as a white-blood-cell count in the CSF of more than 19 per µL for newborn babies (aged ≤28 days), ten per µL or more for infants (aged 29-56 days), and five per µL or more for older children (aged >56 days). 16 Exclusion criteria were refusal of consent from parents, absence of or insufficient blood samples, and bacterial or other viral infections in blood or CSF specimens. We also excluded patients (at a later stage) who were diagnosed

Evidence before this study We searched PubMed up to Feb 7, 2018, for papers reporting paediatric enterovirus diseases and enterovirus PCR testing or molecular detection of viruses in cerebrospinal fluid (CSF) or blood specimens of patients with aseptic meningitis, sepsis and sepsis-like disease, or fever without source. We used the search terms "enterovirus", "nonpolio enterovirus", "meningitis", "viral meningitis", "aseptic meningitis", "enterovirus meningitis", "acute meningitis", "sepsis", "sepsis-like disease", "fever", "fever without source", "genome detection", "enterovirus detection", "enterovirus RT-PCR", "molecular detection", "viremia", "viremic", "virus load", "blood", "plasma", and "cerebrospinal fluid". We also reviewed references from relevant articles not identified in the original search. Our search identified 12 studies in which enterovirus detection was reported in blood and CSF. Most studies were retrospective, the number of patients recruited varied between 11 and 34, and blood samples were not obtained in all patients whose CSF was tested. Two studies of 80 and 122 patients aged 90 days or younger with enterovirus infection were referenced to discuss our enterovirus detection frequency in the blood and CSF of febrile infants. In a study of 75 patients aged 16 years or younger with aseptic meningitis, 76% had enterovirus detected in blood samples by PCR. However, in that study, age groups were not analysed separately. In all these studies, symptom duration before lumbar puncture or venepuncture, and time between CSF and blood collection, were not recorded.

Our study of 360 patients with laboratory findings of enterovirus infection is, as far as we are aware, the largest prospective, multicentre, observational study to assess PCR testing for enterovirus in both blood and CSF samples from newborn babies (aged ≤28 days) and infants (aged >28 days to ≤2 years) with fever without source, sepsis-like disease, or suspected meningitis, and children (aged >2 years to ≤16 years) with suspected meningitis. To our knowledge, our study is the first to show that sensitivity of enterovirus detection in blood samples is related to patients' age and clinical presentation. Detection of enterovirus was more frequent in blood samples than in CSF specimens of newborn babies and infants with fever without source or sepsis-like diseases, and it was less frequent in blood samples of patients with suspected meningitis. Furthermore, our study showed that enterovirus positivity in blood was related inversely to patient's age with meningitis.

At present, blood samples from febrile patients in the paediatric emergency department are not sent routinely for enterovirus PCR testing, and only CSF samples are sent for infants younger than 90 days or for patients with suspected meningitis. Guidelines for biological management of patients aged 2 years or younger with febrile illness in the emergency department need to be reconsidered. When blood is sampled for a complete blood count, an additional blood tube should be obtained for enterovirus PCR testing, which can now be done sufficiently rapidly to have a real effect on infection management. PCR testing of blood samples done in routine practice could result in a more accurate assessment of the actual number of positive cases in patients with suspected meningitis, sepsis-like diseases, and fever without source. A positive enterovirus diagnosis could affect beneficially decisions about a patient's management, by reducing antibiotic or antiviral therapy, avoiding ancillary tests, lowering hospital-related costs, and allowing earlier discharge.

with infections in other biological specimens (eg, urine, nasopharyngeal aspirate, or stool).

The study was approved by the French ethics committee (AU1180), under the Institutional Review Board number 00008526. We obtained verbal consent for use of clinical samples for research from parents or guardians of children aged 8 years or younger and from children older than 8 years.

Within 24 h of admission, a doctor completed a standardised questionnaire for every patient, with details of the nature and duration of preadmission symptoms and signs and the results of a physical examination done at the time of admission. Laboratory findings comprised the date and time at which biological specimens were taken, CSF and full blood count characteristics, C-reactive protein assay, and the results of other bacteriological and virological testing of samples recorded by biologists. Symptom duration was the interval between onset of symptoms and venepuncture (and lumbar puncture, if indicated). We estimated the onset of symptoms as either 8 am, 2 pm, 8 pm, or 2 am when symptoms were recorded in the morning, afternoon, evening, and night, respectively. CSF protein concentration was classified as normal if it was 0·9 g/L or lower for newborn babies (aged ≤28 days) and 0·45 g/L or lower for older children (aged >28 days). Investigation for urinary-tract infection in febrile patients was done with urine dipsticks and confirmed by culture of specimens obtained from urethral catheters. A urinary-tract infection was diagnosed as leucocytosis (≥10⁴ cells per mL) and clinically significant bacteria (≥10⁵ colony-forming units per mL) in urine culture. All samples were submitted for routine bacteriological and virological investigations at every participating hospital, according to local practice. A senior paediatrician and the study team reviewed the final diagnosis at discharge.

We did PCR testing for enterovirus in blood and CSF specimens at microbiology laboratories of five participating hospitals: Centre Hospitalier Universitaire (CHU) de Clermont-Ferrand (Clermont-Ferrand), Cochin Hospital (Assistance Publique-Hôpitaux de Paris, Paris), Grand Hôpital de l'Est Francilien, site de Meaux (Meaux), Centre Hospitalier de Versailles André Mignot (Versailles), and CHU de Rennes (Rennes). We used commercial (Xpert EV, Cepheid, Sunnyvale, CA, USA [only used with CSF samples]; Enterovirus R-GENE, bioMérieux, Marcy l'Etoile, France; and O-DiaENT, Diagenode, Seraing, Belgium) or in-house 17 RT-PCR assays. A diagnosis of enterovirus was established with positive PCR findings in either plasma or CSF, or both. For specimens negative for enterovirus on PCR testing, and if the volume of sample remaining was sufficient, we did a specific RT-PCR parecho virus assay in blood and CSF (Parechovirus R-GENE, bioMérieux). We typed enterovirus-positive specimens at the National Reference Centre for Enteroviruses and Parechoviruses (Clermont-Ferrand, France) by amplification and sequencing of the VP1 capsid protein. 18 

We did statistical analyses with Stata 13. Statistical tests were two-sided with a type I error set at an α of 0·05. We presented continuous data as median (IQR) for every age group (newborn babies, infants, and children). We estimated κ coefficients and sensitivity, specificity, and predictive values (with 95% CIs) for blood enterovirus PCR testing and compared these with values in CSF to ascertain validity. We judged κ values according to recommendations: less than 0·2 (negligible), 0·2-0·4 (low or weak consistency), 0·4-0·6 (moderate agreement), 0·6-0·8 (substantial or good agreement), and greater than 0·8 (excellent agreement). 19 For comparisons between groups, we used χ² or Fisher's exact tests for categorical variables, then (when appropriate) we did Marascuilo's procedure. For quantitative parameters, we used Student's t test or the Mann-Whitney test when assumptions of the t test were not met. We did a regression model for newborn babies and infants to identify factors that were associated independently with viraemia, using a stepwise (backward and forward) approach. We ascertained covariates according to univariate results (entry at p=0·15) and relevant biological and clinical variables-eg, CSF whiteblood-cell count, duration of symptoms, tachycardia, hypotonia, irritability, and seizure (adjustment factors). We paid attention to multicollinearity. We expressed results as odds ratios (ORs) and 95% CIs, and we represented findings using forest plots.

We did a sensitivity analysis for multivariate analysis, which we applied to all groups. We also did a sensitivity analysis to assess the effect of any inaccurate dates or times of symptom onset recorded by parents.

The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report. CA and AL had full access to all data in the study and had final responsibility for the decision to submit for publication. CSF=cerebrospinal fluid. *Parents did not agree to participation of their child after reading the information leaflet. †PCR inhibitors were present either in blood (n=3) or in CSF (n=3) samples. Of those with PCR inhibitors in blood, two had negative CSF (one infant and one child) and one had positive CSF (newborn baby). Of those with PCR inhibitors in CSF, one had negative blood (infant) and two had positive blood (newborn baby and infant). Three patients had enterovirus infection. All six patients were excluded from the analysis. 355 Data are n (%) or median (IQR), unless otherwise indicated. CSF=cerebrospinal fluid. +=enterovirus PCR positive. -=enterovirus PCR negative. *Time between onset of symptoms and venepuncture or lumbar puncture was significant between children and infants and between children and newborn babies (p<0·0001). †Time between onset of symptoms and lumbar puncture was significant between infants and newborn babies (p=0·045). A multivariate analysis that adjusted for age, duration of symptoms, hypotonia, irritability, and all factors judged significant in univariate analysis confirmed that patient's age, tachycardia, and exposure to a sick contact were associated significantly with viraemia in patients aged 2 years or younger (figure 2A). In a further multivariate analysis, including patients in all three age groups, the time between onset of symptoms and venepuncture (<24 h, OR 2·96, 95% CI 1·57-5·58; p=0·001; 24 h to <48 h, 2·55, 1·27-5·11; p=0·008) and pleocytosis (7·60, 4·34-13·32; p<0·0001) were also associated with viraemia ( figure 2B) . Data for patients in each age group with and without enterovirus infection, who had samples available for PCR testing, were compared for differences in symptoms and laboratory characteristics ( (p=0·042), hypotonia (p=0·012), and nausea or vomiting (p<0·0001) than were those without infection. Patients of all ages infected with enterovirus were more likely to have been exposed to a sick contact than were those without infection (p≤0·003). Newborn babies infected with enterovirus were more likely to show symptoms of irritability (p=0·001) and hypotonia (p=0·033) compared with those testing negative for enterovirus. Tachycardia was more frequent in infants infected with enterovirus than in those not infected with enterovirus (p=0·005). All patients recovered from the enterovirus infection. Pleocytosis was recorded in 192 (66%) of 292 patients infected with enterovirus compared with 59 (24%) of 246 who were not infected (p=0·0001). Pleocytosis increased with patient's age, with 20 (35%) of 58 newborn babies, 33 (47%) of 71 infants, and 139 (85%) of 163 children having pleocytosis. Amounts of protein in CSF were similar in patients infected and not with enterovirus. Blood lymphocyte counts were lower in patients of all ages infected with enterovirus than in those not infected (p≤0·044).

Prospective enterovirus typing was done for 311 (86%) of 360 patients whose CSF or blood specimens, or both, were positive for enterovirus (appendix p 2). Viral strains were assigned to 29 different types, eight within the entero virus A species (29 patients) and 21 within the enterovirus B species (282 patients). The enterovirus genotypes E9, E25, E7, and CVB5 were more frequent in newborn babies than in infants and children; patients with suspected sepsis were more likely to be infected with E25 genotype than were patients with other clinical presentations; and those with suspected meningitis were more frequently infected with E30, E6, or CVB5 genotypes.

Our study shows that, in newborn babies and infants, the sensitivity of enterovirus PCR testing is higher in blood samples than in CSF specimens. This finding substantiates those of previous single-centre studies [7] [8] [9] and lends support to use of blood enterovirus testing as a diagnostic adjunct to rapidly identify newborn babies and infants admitted with fever without source, sepsislike disease, or suspected meningitis whose antibiotic treatment can be discontinued and who are eligible for discharge. Our study also shows that blood enterovirus PCR testing in children with suspected meningitis has no additional benefit compared with PCR testing in CSF. 

Seizures Tachycardia Exposure to a sick contact Hypotonia Irritability Time between onset of symptoms and blood sample ≥48 h Time between onset of symptoms and blood sample 24-48h Time between onset of symptoms and blood sample <24h White blood cell count Pleocytosis C-reactive protein level (>15 mg/L) This lower sensitivity, compared with that recorded in newborn babies and infants, was attributable mainly to the long period between onset of symptoms and venepuncture.

To our knowledge, we report here the largest, prospective, multicentre, observational study to show that positive detection of enterovirus in blood is associated with patient's age and clinical presentation. Detection of enterovirus was significantly higher in blood samples than in CSF specimens from newborn babies and infants and varied by clinical presentation, with detection higher in patients admitted with fever without source or sepsis-like diseases than in those with suspected meningitis. A positive result for enterovirus in blood samples from patients with suspected meningitis was related inversely to age, with higher detection in newborn babies (97%), then infants (87%), then children (55%).

Compared with previous reports, enterovirus was detected in blood samples from newborn babies and infants more frequently in our study. In a study of 122 infants (aged ≤90 days) with fever who were infected with enterovirus, PCR yielded equally positive results in blood samples and CSF specimens (77% and 83%, respectively). 7 In another study of 80 infants with suspected sepsis, detection of enterovirus was similar in blood and CSF samples (69% vs 78%). 8 Our study followed guidelines from the UK National Institute for Health and Care Excellence (NICE) for clinical management in emergency departments of newborn babies, infants, and children with febrile illness, 20 . These data suggest that viraemia occurs early and is of short duration, a finding rarely noted in other reports and only with small patient populations. 21, 22 In some biological diagnostic practices, CSF PCR testing is done only in patients with pleocytosis. In our study, we did lumbar puncture in 675 patients, of whom 371 did not have pleocytosis (data not shown). In these patients, however, enterovirus was detected in CSF (n=70) and blood (n=98). Without detection of enterovirus in blood or CSF samples, these patients without pleocytosis would have been discharged without aetiological diagnosis. Thus, the diagnostic practice to do enterovirus testing solely in patients with pleocytosis can lead to enterovirus infections being missed. Moreover, 144 patients had enterovirus PCR testing done only in blood samples, of whom 40 (28%) had enterovirus infection-mostly newborn babies or infants with fever without source. Ahmad and colleagues detected enterovirus in blood samples from 34 (24%) of 139 neonates with sepsis-like illness. 11 The diversity of prevailing enterovirus genotypes during the two seasons of the present study and differences in the distribution of genotypes among age 

White-blood-cell count (× 10⁹ per L) 23 Harvala and colleagues 24 reported higher or similar viral loads in CSF compared with plasma in 11 children younger than 3 years with CNS disease. They found low or undetectable CSF viral loads and high plasma viral loads in 14 children with sepsis. A previous study by our group 25 showed that among 156 patients with acute meningitis, enterovirus viral loads in CSF were higher in newborn babies than in infants and adults and that genotypes were associated with different viral loads. The analysis of clinical and biological characteristics in patients aged 2 years or younger showed that viraemia was detected more frequently in younger infants (median age 28 days [IQR 17-41]) with acute-stage disease, as suggested in earlier retrospective studies of smaller patient populations. 21, 22 Clinically, tachycardia was present in 62 (50%) of 125 young patients with viraemia and fever without source, sepsis, or suspected meningitis. Other reports have cited fever, irritability, lethargy, and poor feeding in patients with enterovirus viraemia. 11, 21 In our study, patients with enterovirus viraemia were also more likely to have been exposed to a sick contact.

All patients with viraemia in our study were febrile. Amounts of C-reactive protein in serum greater than 15 mg/L were detected more frequently in patients without viraemia. Pleocytosis was noted in 44 (38%) of 116 patients with enterovirus viraemia, mainly those with suspected meningitis (data not shown). Dagan and colleagues 21 reported an inverse relation between viraemia and pleocytosis. The number of lymphocytes and monocytes was significantly lower in patients with viraemia than in those without viraemia. This finding and earlier data 21,26 suggest a detrimental effect of enterovirus infection on populations of mononuclear leucocytes during viraemia. This effect can be caused by virus replication in mononuclear leucocytes, because some enterovirus genotypes can replicate in vitro in human peripheral blood mononuclear cells. 27, 28 Accordingly, the concentrations of circulating mono nuclear cells at different ages and the ability of entero virus genotypes to replicate in these cells can affect the sensitivity of blood enterovirus detection.

Concomitant bacterial infections, mostly urinary-tract infections, occurred in a small proportion (22 [6%] of 360) of patients with fever and enterovirus infection. Amounts of C-reactive protein in serum greater than 15 mg/L were noted in five (23%) of these patients (data not shown). The frequency of concomitant enterovirus and bacterial infections was consistent with that in other studies. 7, 8, 29 No enterovirus and bacterial coinfections were identified in CSF of patients with meningitis and in blood samples of patients with sepsislike disease.

Our study has three limitations. First, the date and time of symptom onset were recorded less reliably by parents of children than by those of newborn babies and infants. A sensitivity analysis (data not shown) excluding the inaccurate dates and times of symptom onset for 190 (23%) of 822 patients did not affect our results. Second, virology management (including detection of viruses other than enterovirus) and bacteriology management varied between the 16 hospitals taking part. In 340 (41%) of 822 patients, no diagnosis was established, a figure similar to that reported by Ahmad and colleagues (43%). 11 Third, four different RT-PCR assays were used in our multicentre study. It is unlikely that this variability affected the overall results, because methods used are assessed annually by an external quality assess ment programme, and all yielded correct results.

In conclusion, detection of enterovirus in blood improved diagnostic yield in newborn babies and infants admitted for fever without source, sepsis-like disease, or suspected meningitis, compared with detection in CSF. The high frequency of detection of enterovirus in blood samples from very young patients with fever without source and sepsis-like disease suggests that enterovirus febrile illnesses are underdiagnosed. It is important to reconsider the guidelines for biological management of patients aged 2 years or younger with febrile illness in emergency departments, to obtain-at the time of blood sampling-an additional tube for enterovirus PCR testing, which can be done sufficiently rapidly to have a real effect on management. A positive enterovirus blood diagnosis could beneficially affect patient management decisions by reducing antibiotic or antiviral therapy, avoiding ancillary tests, lowering hospital-related costs, and allowing earlier discharge. Blood enterovirus genome can also be used as an alternative biomarker in case of contraindications for CSF sampling and failure of lumbar puncture.

Service Urgences Pédiatriques

INSERM, CIC 1405

Service de Microbiologie Clinique des HUPSSD

Service de Microbiologie Clinique des HUPSSD

Service Pédiatrie Générale et Urgences Pédiatriques

Service de Microbiologie et Hygiène, Hôpitaux Universitaires

Service de Pediatrie-Néonatologie

Laboratoire de biologie médicale

Viral infections of the central nervous system in Spain: a prospective study

Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study

Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis

Improvement of the management of infants, children and adults with a molecular diagnosis of enterovirus meningitis during two observational study periods

Recommendations for enterovirus diagnostics and characterisation within and beyond Europe

Epidemiology of a pediatric emergency medicine research network: the PECARN Core Data Project

Diagnosis and outcomes of enterovirus infections in young infants

A polymerase chain reaction-based epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger

Prospective comparison of the detection rates of human enterovirus and parechovirus RT-qPCR and viral culture in different pediatric specimens

Epidemiology of sepsis-like illness in young infants: major role of enterovirus and human parechovirus

Frequency of enterovirus detection in blood samples of neonates admitted to hospital with sepsis-like illness in Kuwait

Enterovirus and parechovirus viraemia in young children presenting to the emergency room: unrecognised and frequent

Surveillance of enteroviruses in France

Management of fever without source in infants and children

Report on the Expert Meeting on neonatal and paediatric sepsis

Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants

Rapid routine detection of enterovirus RNA in cerebrospinal fluid by a one-step real-time RT-PCR assay

Prospective identification of enteroviruses involved in meningitis in 2006 through direct genotyping in cerebrospinal fluid

Quality criteria were proposed for measurement properties of health status questionnaires

Fever in under 5s: assessment and initial management-clinical guideline (CG160)

Viremia in hospitalized children with enterovirus infections

The correlation between the presence of viremia and clinical severity in patients with enterovirus 71 infection: a multi-center cohort study

Point sur les infections à entérovirus au 9 décembre

Distinct systemic and central nervous system disease patterns in enterovirus and parechovirus infected children

Variations in cerebrospinal fluid viral loads among enterovirus genotypes in patients hospitalized with laboratory-confirmed meningitis due to enterovirus

Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations

Replication of enteroviruses in human mononuclear cells

Enterovirus receptors and virus replication in human leukocytes

Enterovirus neurological disease and bacterial coinfection in very young infants with fever

This study was supported by a grant from the University Hospital of Clermont-Ferrand AOI (Appel d'Offre Interne) 2015. We gratefully acknowledge the Blood Enterovirus Diagnosis Infection (BLEDI) in paediatric population study team, who contributed to data collection from 16 French participating hospitals. We thank Emilie Leroy and Nathalie Rodde for assistance with virus genotyping; and Jeffrey Watts for help preparing the Article (funded with a grant from the University Hospital of Clermont-Ferrand AOI 2015).

